Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

797
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
797
Flail Chest-II01:26

Flail Chest-II

929
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
929
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

752
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
752
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

602
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
602
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

701
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
701
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.6K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying discrepancy between indicated and actual oxygen flow rates delivered by Comweld Ezi-flow low and standard flowmeters under hyperbaric conditions: a technical report.

Diving and hyperbaric medicine·2026
Same author

Challenges of delivering a lifestyle intervention before surgery in multiple surgical specialties in the NHS: experience from the INSPIRE trial.

Trials·2026
Same author

Standards for reporting research methods, interventions, and Outcomes in Surgical Prehabilitation studies (SOS-Prehab).

The British journal of surgery·2026
Same author

Novel use of hyperbaric oxygen treatment for treatment-resistant disseminated Saksenaea and Fusarium in a patient on extracorporeal membrane oxygenation (ECMO): a case report.

Diving and hyperbaric medicine·2025
Same author

The process, logistics and governance behind a high-stakes novel intervention: the use of extracorporeal membrane oxygenation (ECMO) in the hyperbaric chamber.

Diving and hyperbaric medicine·2025
Same author

Validation and clinical use of the Maquet (Getinge) original series Rotaflow extracorporeal membrane oxygenation device in hyperbaric conditions: a technical report.

Diving and hyperbaric medicine·2025
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
04:01

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis

Published on: September 8, 2022

3.2K

Adjunctive hyperbaric oxygen for necrotizing fasciitis.

Denny Levett1, Michael H Bennett, Ian Millar

  • 1Anaesthesia and Critical Care Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. denny.levett@ucl.ac.uk.

The Cochrane Database of Systematic Reviews
|April 17, 2015
PubMed
Summary
This summary is machine-generated.

This review found no clinical trials on hyperbaric oxygen therapy (HBOT) for necrotizing fasciitis. More research is needed to determine if HBOT is effective for this serious infection.

More Related Videos

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

740

Related Experiment Videos

Last Updated: Apr 14, 2026

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
04:01

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis

Published on: September 8, 2022

3.2K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

740

Area of Science:

  • Hyperbaric medicine
  • Infectious diseases
  • Surgical critical care

Background:

  • Hyperbaric oxygen therapy (HBOT) utilizes 100% oxygen in a pressure chamber.
  • HBOT is explored as an adjunct treatment for necrotizing fasciitis (NF) to reduce mortality and morbidity.
  • Necrotizing fasciitis is a severe bacterial infection requiring prompt medical and surgical intervention.

Purpose of the Study:

  • To review existing evidence on HBOT as an adjunctive treatment for necrotizing fasciitis.
  • To determine if HBOT reduces mortality or morbidity in NF patients.
  • To identify adverse effects associated with HBOT in NF treatment.

Main Methods:

  • Comprehensive literature search of multiple databases (CENTRAL, MEDLINE, CINAHL, EMBASE) and specialized hyperbaric medicine sources.
  • Inclusion criteria focused on randomized and pseudo-randomized trials comparing HBOT with no HBOT for necrotizing fasciitis.
  • Independent data collection by two reviewers using standardized forms was planned.

Main Results:

  • No trials meeting the inclusion criteria were identified in the systematic search.
  • The review could not locate any studies evaluating HBOT for necrotizing fasciitis.

Conclusions:

  • The current systematic review found no clinical evidence to support or refute the effectiveness of HBOT for necrotizing fasciitis.
  • High-quality clinical trials are essential to establish the role of HBOT in managing necrotizing fasciitis.
  • Further research is required to understand the potential benefits and risks of HBOT in this patient population.